Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Ralph Fiore , DO

Dermatology • Chicago, IL

Active NPI 1770524043 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

1725 W Harrison St Ste 264
Chicago, IL 606123844

Call 3129422195 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

1725 W Harrison St Ste 264

Chicago, IL 606123844

Telephone 3129422195
Organization at the Same NPPES Address or Phone
Rush University Medical Center Facility NPI 1457360703

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Dermatology Associates Ltd. See the list

Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File

Medical School

Midwestern University, Chicago College Of Osteopathic Med

Graduation Year

2009

Medicare patients

1,191 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $322,865 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $230,995 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

1,453 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$345,388 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $9,511.59 across 104 records.

By nature of payment

  • Consulting Fee: $6,336.00 across 1 record.
  • Food and Beverage: $2,260.88 across 100 records.
  • Travel and Lodging: $914.71 across 3 records.

Reporting-company totals (3 largest of 17)

  • Sanofi and Genzyme US Companies: $7,342.79 across 9 records.
  • Arcutis Biotherapeutics, Inc.: $320.21 across 25 records.
  • UCB, Inc.: $292.29 across 8 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

17 years (graduated 2009)

CMS Doctors and Clinicians data list 2009 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File.

NPI first issued

2006

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Fiore has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Fiore as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Chicago and Illinois

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Dermatology in Chicago, IL (2024, 113 clinicians with data). Median for this group: 734. Middle half: 298 to 1,752.

More Medicare Part B services than 80% of clinicians listed under Dermatology in Illinois (2024, 405 clinicians with data). Median for this group: 2,033. Middle half: 899 to 4,119.

Medicare-allowed amount

A higher Medicare-allowed amount than 95% of clinicians listed under Dermatology in Chicago, IL (2024, 113 clinicians with data). Median for this group: $55,579. Middle half: $21,156 to $115,126.

A higher Medicare-allowed amount than 75% of clinicians listed under Dermatology in Illinois (2024, 405 clinicians with data). Median for this group: $141,868. Middle half: $64,155 to $281,967.

Paid by Medicare

A higher Medicare payment amount than 95% of clinicians listed under Dermatology in Chicago, IL (2024, 113 clinicians with data). Median for this group: $38,442. Middle half: $14,571 to $82,347.

A higher Medicare payment amount than 75% of clinicians listed under Dermatology in Illinois (2024, 405 clinicians with data). Median for this group: $99,602. Middle half: $44,437 to $204,261.

Medicare Part D prescriptions

More Part D prescriptions than 95% of clinicians listed under Dermatology in Chicago, IL (2024, 146 clinicians with data). Median for this group: 223. Middle half: 94 to 508.

More Part D prescriptions than 85% of clinicians listed under Dermatology in Illinois (2024, 468 clinicians with data). Median for this group: 471. Middle half: 165 to 904.

Part D drug cost

A higher Part D drug cost than 85% of clinicians listed under Dermatology in Chicago, IL (2024, 146 clinicians with data). Median for this group: $50,146. Middle half: $2,705 to $189,548.

A higher Part D drug cost than 75% of clinicians listed under Dermatology in Illinois (2024, 468 clinicians with data). Median for this group: $69,576. Middle half: $5,709 to $275,598.

233 active clinicians are listed under Dermatology with a practice address in Chicago, IL (647 in Illinois).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Chicago

10.3% of these 233 clinicians have the CMS telehealth indicator.

54.9% of these 233 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 104 records totaling $9,511.59.

Manufacturer Payment Nature Product Type Amount ($)
Sanofi and Genzyme US Companies
Consulting Fee
Cash or cash equivalent
DUPIXENT General $6,336.00
Sanofi and Genzyme US Companies
Travel and Lodging
In-kind items and services
DUPIXENT General $469.40
Sanofi and Genzyme US Companies
Travel and Lodging
In-kind items and services
DUPIXENT General $293.21
Arcutis Biotherapeutics, Inc.
Food and Beverage
In-kind items and services
Zoryve General $167.14
Pfizer Inc.
Travel and Lodging
In-kind items and services
CIBINQO General $152.10
Incyte Corporation
Food and Beverage
Cash or cash equivalent
OPZELURA General $86.56
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $71.88
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $48.52
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $44.42
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $42.42
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $42.27
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $42.06
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $41.39
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $39.89
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $38.93
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
LIBTAYO General $38.44
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $38.27
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $36.93
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $35.60
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $35.10
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
— General $33.83
Boehringer Ingelheim Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
SPEVIGO General $33.77
Organon LLC
Food and Beverage
In-kind items and services
— General $33.76
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
COSENTYX General $33.63
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
COSENTYX General $33.14

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
17003 Destruction of precancer skin growth, 2-14 growths
2,105 370 $15.00 $6.71
17000 Destruction of precancer skin growth, 1 growth
604 482 $132.00 $50.72
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
589 521 $175.00 $93.83
17110 Destruction of skin growth, 1-14 growths
458 386 $223.00 $106.83
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
440 346 $248.00 $131.74
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
149 149 $220.00 $115.72
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
120 120 $337.00 $172.51
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
107 99 $35.00 $16.66
11310 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less
91 83 $233.00 $105.67
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
90 59 $290.00 $129.90
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
71 65 $244.00 $114.73
11102 Biopsy of related skin growth, first growth
56 54 $203.00 $81.31
11311 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
53 49 $275.00 $134.47
11306 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
45 39 $245.00 $109.17
11200 Removal of skin tag, 1-15 skin tags
40 40 $177.00 $68.35
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
37 27 $350.00 $172.14
96574 Application of light with debridement to destroy precancer skin growth
29 29 $564.00 $284.62
11305 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less
28 26 $212.00 $77.13
96372 Injection of drug or substance under skin or into muscle
27 11 $40.00 $14.63
17004 Destruction of precancer skin growth, 15 or more growths
22 20 $323.00 $173.01
11302 Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm
18 15 $279.00 $125.26
11900 Injection into skin growth, 1-7 growths
17 16 $111.00 $43.78
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
11 11 $603.00 $314.29

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Triamcinolone Acetonide Triamcinolone Acetonide 252 8,560 $2,602.52 187
Betamethasone Dipropionate Betamethasone Dipropionate 123 3,148 $4,181.47 79
Hydrocortisone Hydrocortisone 110 3,016 $1,155.66 88
Mupirocin Mupirocin 92 2,077 $703.06 78
Ketoconazole Ketoconazole 90 2,836 $1,986.51 54
Doxycycline Hyclate Doxycycline Hyclate 87 2,541 $2,052.61 60
Clobetasol Propionate Clobetasol Propionate 65 1,928 $4,357.54 47
Dupixent Pen Dupilumab 50 1,344 $199,463.77 —
Clindamycin Phosphate Clindamycin Phosphate 43 1,259 $1,652.31 35
Desonide Desonide 42 1,268 $4,321.16 34
Tacrolimus Tacrolimus 41 1,435 $6,778.33 29
Azelaic Acid Azelaic Acid 37 1,545 $5,517.97 28
Zoryve Roflumilast 29 975 $24,510.13 12
Metronidazole Metronidazole 27 970 $1,246.67 22
Acitretin Acitretin 25 870 $7,480.90 —
Minoxidil Minoxidil 23 1,050 $197.48 —
Fluocinonide Fluocinonide 22 566 $855.81 14
Ciclopirox Ciclopirox Olamine 20 615 $516.19 —
Fluconazole Fluconazole 18 483 $347.41 —
Valacyclovir Valacyclovir Hcl 16 222 $229.12 14
Otezla Apremilast 15 450 $72,786.90 —
Prednisone Prednisone 14 164 $36.39 13
Nystatin Nystatin 14 405 $142.40 —
Tretinoin Tretinoin 14 545 $1,850.15 —
Doxycycline Monohydrate Doxycycline Monohydrate 11 360 $273.41 —

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2021-12-08
Dermatology Primary Specialty

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES IL 036.131170

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Illinois Department of Financial and Professional Regulation.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20181109001074

Enrollment State Jurisdiction

IL

PECOS Control ID

7618958422

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File

Dermatology Associates Ltd

18425 W Creek Dr, Tinley Park, IL 604776768

Phone: 7084448300

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

6 listed
Sarah Anderson , PA-C

Physician Assistant

NPI 1821561077

Physician Assistant (Certified)

Dr. Sherri Korman , MD

Student in an Organized Health Care Education/Training Program

NPI 1477874071

Doctor of Medicine (M.D.)

NPI 1063886844

Doctor of Medicine (M.D.)

Dr. Maxim Polansky , MD

Dermatology - MOHS-Micrographic Surgery

NPI 1275913006

Doctor of Medicine (M.D.)

NPI 1306092267

Doctor of Medicine (M.D.)

Maureen Riegert

Dermatology

NPI 1295228351

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

9 Historical Events
📍
Updated Practice Location June 25, 2020

Registered at 1725 W HARRISON ST STE 264, CHICAGO, IL 606123844 (Tel: 3129422195)

📍
Updated Business Mailing Address June 25, 2020

Registered at 1725 W HARRISON ST STE 264, CHICAGO, IL 606123844 (Tel: 3129422195)

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) June 25, 2020

Dermatology (license number reported to NPPES: IL 036.131170)

âś…
NPI Profile Active October 26, 2016

NPI status registered as active in NPPES database

📍
Practice Location (Initial Record) October 26, 2016

Registered at 3601 30TH AVE, SUITE 201, KENOSHA, WI 531441695 (Tel: 2628984400)

📍
Business Mailing Address (Initial Record) October 26, 2016

Registered at 801 YORK ST, MANITOWOC, WI 542204630 (Tel: 9206639146)

👤
Provider Name / Credentials (Initial Record) October 26, 2016

Recorded as RALPH FIORE, D.O

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) October 26, 2016

Dermatology (license number reported to NPPES: IL 036.131170)

🟢
Initial NPI Registration & Enumeration June 09, 2006

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1770524043
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: June 09, 2006
Last Update: December 08, 2021
Sole Proprietor: No

Other Dermatology Specialists in Chicago

All Dermatology Specialists in Chicago

Mailing Address

1725 W Harrison St Ste 264

Chicago, IL 606123844

Phone: 3129422195

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.